Denosumab Approved in Europe for Myeloma

The European Commission has approved denosumab for the prevention of skeletal-related events in adult patients with multiple myeloma.

Read full article (External website)

1 reply

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply